Abstract

Adipocyte is an important place for lipid storage. Defects in lipid storage in adipocytes can lead to lipodystrophy and lipid accumulation in muscle, liver, and other organs. It is the condition of mixed dyslipidemia which may favor the development of insulin resistance via lipotoxic mechanisms. Our objective of the study was to investigate the potential role of R-limonene (LM) on differentiation, lipid storage, and 2-deoxy-D-glucose (2DG) uptake in 3T3-L1 preadipocytes. Genes and proteins associated with differentiation, lipid accumulation, 2DG uptake and its signaling pathways in the adipocytes were analyzed using qPCR and western blot methods. LM treatment increased differentiation, lipid accumulation, and the expression of adipogenic and lipogenic markers such as C/EBP-α, C/EBP-β, PPARγ, SREBP-1, RXR, FAS, and adiponectin. However, the LM concentration at 10μM decreased (p < 0.05) adipogenesis and lipogenesis via regulating key transcriptional factors. LM treatment increased activation of Akt by increasing its phosphorylation, but p44/42 activation was not altered. MK-2206, an Akt specific inhibitor, reduced the activation of Akt phosphorylation whereas LM treatment aborted the MK-2206 mediated inhibition of Akt activation. LM enhanced glucose uptake in differentiated adipocytes. Overall data suggested that LM treatment favored lipid storage and glucose uptake in adipocytes via activation of key transcriptional factors through activation of Akt phosphorylation in 3T3-L1 adipocytes.

Highlights

  • Differentiation of adipocytes is an essential process for the lipid storage

  • Inhibiting adipocyte differentiation alone is not an appropriate way to prevent obesity because adipocytes provide a safe place for lipid accumulation

  • Preadipocytes were treated with different concentrations (10μM to 300 μM) of LM and incubated for 1 day, 2 days, and 10 days

Read more

Summary

Introduction

Differentiation of adipocytes is an essential process for the lipid storage. Defects in adipogenesis can lead to stimulating lipodystrophy. In this condition, lipids are accumulated in muscle, liver, and other organs which develop the insulin resistance [1, 2]. Adipogenesis is a complex process that is regulated by a cascade of transcription factor and other regulatory proteins. C/EBP-β (CCAAT/enhancer-binding protein-β) and C/EBPδ act together and induce the expression of PPAR-γ 2 (peroxisome proliferator-activated receptor) and C/EBP-α (CCAAT/enhancer-binding protein-α). These factors are known to regulate genes and proteins associated with adipogenesis and lipogenesis [8]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call